"World's Most Complete Market Research Reports Repository"

Global Exocrine Pancreatic Insufficiency Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category :
  • |
  • ID : 653800
  • |
  • Publishe Date : 10-Oct-18
  • |
  • No of Pages: 130
  • |
  • Publisher : Global Info Research

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.



Scope of the Report:

This report studies the Exocrine Pancreatic Insufficiency market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Exocrine Pancreatic Insufficiency market by product type and applications/end industries.

EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.

The global Exocrine Pancreatic Insufficiency market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Exocrine Pancreatic Insufficiency.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

Axcan Pharma

Aptalis Pharma

Eli Lilly

Cilian

Nordmark Arzneimittel

Laboratoires Mayoly Spindler



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Nutritional management

Pancreatic enzyme replacement therapy (PERT)

Life style modifications approach



Market Segment by Applications, can be divided into

Nutritional management

Pancreatic enzyme replacement therapy (PERT)

Life style modifications approach

Table of Contents



1 Exocrine Pancreatic Insufficiency Market Overview

1.1 Product Overview and Scope of Exocrine Pancreatic Insufficiency

1.2 Classification of Exocrine Pancreatic Insufficiency by Types

1.2.1 Global Exocrine Pancreatic Insufficiency Revenue Comparison by Types (2017-2023)

1.2.2 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Types in 2017

1.2.3 Nutritional management

1.2.4 Pancreatic enzyme replacement therapy (PERT)

1.2.5 Life style modifications approach

1.3 Global Exocrine Pancreatic Insufficiency Market by Application

1.3.1 Global Exocrine Pancreatic Insufficiency Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Nutritional management

1.3.3 Pancreatic enzyme replacement therapy (PERT)

1.3.4 Life style modifications approach

1.4 Global Exocrine Pancreatic Insufficiency Market by Regions

1.4.1 Global Exocrine Pancreatic Insufficiency Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Exocrine Pancreatic Insufficiency Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Exocrine Pancreatic Insufficiency Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Exocrine Pancreatic Insufficiency Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Exocrine Pancreatic Insufficiency Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Exocrine Pancreatic Insufficiency Status and Prospect (2013-2023)

1.5 Global Market Size of Exocrine Pancreatic Insufficiency (2013-2023)

2 Manufacturers Profiles

2.1 Axcan Pharma

2.1.1 Business Overview

2.1.2 Exocrine Pancreatic Insufficiency Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Axcan Pharma Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

2.2 Aptalis Pharma

2.2.1 Business Overview

2.2.2 Exocrine Pancreatic Insufficiency Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Aptalis Pharma Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Exocrine Pancreatic Insufficiency Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

2.4 Cilian

2.4.1 Business Overview

2.4.2 Exocrine Pancreatic Insufficiency Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Cilian Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

2.5 Nordmark Arzneimittel

2.5.1 Business Overview

2.5.2 Exocrine Pancreatic Insufficiency Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

2.6 Laboratoires Mayoly Spindler

2.6.1 Business Overview

2.6.2 Exocrine Pancreatic Insufficiency Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

3 Global Exocrine Pancreatic Insufficiency Market Competition, by Players

3.1 Global Exocrine Pancreatic Insufficiency Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Exocrine Pancreatic Insufficiency Players Market Share

3.2.2 Top 10 Exocrine Pancreatic Insufficiency Players Market Share

3.3 Market Competition Trend

4 Global Exocrine Pancreatic Insufficiency Market Size by Regions

4.1 Global Exocrine Pancreatic Insufficiency Revenue and Market Share by Regions

4.2 North America Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

4.3 Europe Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

4.5 South America Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

5 North America Exocrine Pancreatic Insufficiency Revenue by Countries

5.1 North America Exocrine Pancreatic Insufficiency Revenue by Countries (2013-2018)

5.2 USA Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

5.3 Canada Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

5.4 Mexico Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

6 Europe Exocrine Pancreatic Insufficiency Revenue by Countries

6.1 Europe Exocrine Pancreatic Insufficiency Revenue by Countries (2013-2018)

6.2 Germany Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

6.3 UK Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

6.4 France Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

6.5 Russia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

6.6 Italy Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Exocrine Pancreatic Insufficiency Revenue by Countries

7.1 Asia-Pacific Exocrine Pancreatic Insufficiency Revenue by Countries (2013-2018)

7.2 China Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

7.3 Japan Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

7.4 Korea Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

7.5 India Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

8 South America Exocrine Pancreatic Insufficiency Revenue by Countries

8.1 South America Exocrine Pancreatic Insufficiency Revenue by Countries (2013-2018)

8.2 Brazil Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

8.3 Argentina Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

8.4 Colombia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Exocrine Pancreatic Insufficiency by Countries

9.1 Middle East and Africa Exocrine Pancreatic Insufficiency Revenue by Countries (2013-2018)

9.2 Saudi Arabia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

9.3 UAE Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

9.4 Egypt Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

9.5 Nigeria Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

9.6 South Africa Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

10 Global Exocrine Pancreatic Insufficiency Market Segment by Type

10.1 Global Exocrine Pancreatic Insufficiency Revenue and Market Share by Type (2013-2018)

10.2 Global Exocrine Pancreatic Insufficiency Market Forecast by Type (2018-2023)

10.3 Nutritional management Revenue Growth Rate (2013-2023)

10.4 Pancreatic enzyme replacement therapy (PERT) Revenue Growth Rate (2013-2023)

10.5 Life style modifications approach Revenue Growth Rate (2013-2023)

11 Global Exocrine Pancreatic Insufficiency Market Segment by Application

11.1 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Application (2013-2018)

11.2 Exocrine Pancreatic Insufficiency Market Forecast by Application (2018-2023)

11.3 Nutritional management Revenue Growth (2013-2018)

11.4 Pancreatic enzyme replacement therapy (PERT) Revenue Growth (2013-2018)

11.5 Life style modifications approach Revenue Growth (2013-2018)

12 Global Exocrine Pancreatic Insufficiency Market Size Forecast (2018-2023)

12.1 Global Exocrine Pancreatic Insufficiency Market Size Forecast (2018-2023)

12.2 Global Exocrine Pancreatic Insufficiency Market Forecast by Regions (2018-2023)

12.3 North America Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

12.4 Europe Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

12.6 South America Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Exocrine Pancreatic Insufficiency Picture

Table Product Specifications of Exocrine Pancreatic Insufficiency

Table Global Exocrine Pancreatic Insufficiency and Revenue (Million USD) Market Split by Product Type

Figure Global Exocrine Pancreatic Insufficiency Revenue Market Share by Types in 2017

Figure Nutritional management Picture

Figure Pancreatic enzyme replacement therapy (PERT) Picture

Figure Life style modifications approach Picture

Table Global Exocrine Pancreatic Insufficiency Revenue (Million USD) by Application (2013-2023)

Figure Exocrine Pancreatic Insufficiency Revenue Market Share by Applications in 2017

Figure Nutritional management Picture

Figure Pancreatic enzyme replacement therapy (PERT) Picture

Figure Life style modifications approach Picture

Table Global Market Exocrine Pancreatic Insufficiency Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2013-2023)

Table Axcan Pharma Basic Information, Manufacturing Base and Competitors

Table Axcan Pharma Exocrine Pancreatic Insufficiency Type and Applications

Table Axcan Pharma Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

Table Aptalis Pharma Basic Information, Manufacturing Base and Competitors

Table Aptalis Pharma Exocrine Pancreatic Insufficiency Type and Applications

Table Aptalis Pharma Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Exocrine Pancreatic Insufficiency Type and Applications

Table Eli Lilly Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

Table Cilian Basic Information, Manufacturing Base and Competitors

Table Cilian Exocrine Pancreatic Insufficiency Type and Applications

Table Cilian Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

Table Nordmark Arzneimittel Basic Information, Manufacturing Base and Competitors

Table Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Type and Applications

Table Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

Table Laboratoires Mayoly Spindler Basic Information, Manufacturing Base and Competitors

Table Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Type and Applications

Table Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2016-2017)

Table Global Exocrine Pancreatic Insufficiency Revenue (Million USD) by Players (2013-2018)

Table Global Exocrine Pancreatic Insufficiency Revenue Share by Players (2013-2018)

Figure Global Exocrine Pancreatic Insufficiency Revenue Share by Players in 2016

Figure Global Exocrine Pancreatic Insufficiency Revenue Share by Players in 2017

Figure Global Top 5 Players Exocrine Pancreatic Insufficiency Revenue Market Share in 2017

Figure Global Top 10 Players Exocrine Pancreatic Insufficiency Revenue Market Share in 2017

Figure Global Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Exocrine Pancreatic Insufficiency Revenue (Million USD) by Regions (2013-2018)

Table Global Exocrine Pancreatic Insufficiency Revenue Market Share by Regions (2013-2018)

Figure Global Exocrine Pancreatic Insufficiency Revenue Market Share by Regions (2013-2018)

Figure Global Exocrine Pancreatic Insufficiency Revenue Market Share by Regions in 2017

Figure North America Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Europe Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure South America Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Table North America Exocrine Pancreatic Insufficiency Revenue by Countries (2013-2018)

Table North America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2013-2018)

Figure North America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2013-2018)

Figure North America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2017

Figure USA Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Canada Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Mexico Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Table Europe Exocrine Pancreatic Insufficiency Revenue (Million USD) by Countries (2013-2018)

Figure Europe Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2013-2018)

Figure Europe Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2017

Figure Germany Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure UK Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure France Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Russia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Italy Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Exocrine Pancreatic Insufficiency Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2017

Figure China Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Japan Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Korea Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure India Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Table South America Exocrine Pancreatic Insufficiency Revenue by Countries (2013-2018)

Table South America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2013-2018)

Figure South America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2013-2018)

Figure South America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2017

Figure Brazil Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Argentina Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Colombia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Exocrine Pancreatic Insufficiency Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2017

Figure Saudi Arabia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure UAE Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Egypt Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure Nigeria Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Figure South Africa Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2013-2018)

Table Global Exocrine Pancreatic Insufficiency Revenue (Million USD) by Type (2013-2018)

Table Global Exocrine Pancreatic Insufficiency Revenue Share by Type (2013-2018)

Figure Global Exocrine Pancreatic Insufficiency Revenue Share by Type (2013-2018)

Figure Global Exocrine Pancreatic Insufficiency Revenue Share by Type in 2017

Table Global Exocrine Pancreatic Insufficiency Revenue Forecast by Type (2018-2023)

Figure Global Exocrine Pancreatic Insufficiency Market Share Forecast by Type (2018-2023)

Figure Global Nutritional management Revenue Growth Rate (2013-2018)

Figure Global Pancreatic enzyme replacement therapy (PERT) Revenue Growth Rate (2013-2018)

Figure Global Life style modifications approach Revenue Growth Rate (2013-2018)

Table Global Exocrine Pancreatic Insufficiency Revenue by Application (2013-2018)

Table Global Exocrine Pancreatic Insufficiency Revenue Share by Application (2013-2018)

Figure Global Exocrine Pancreatic Insufficiency Revenue Share by Application (2013-2018)

Figure Global Exocrine Pancreatic Insufficiency Revenue Share by Application in 2017

Table Global Exocrine Pancreatic Insufficiency Revenue Forecast by Application (2018-2023)

Figure Global Exocrine Pancreatic Insufficiency Market Share Forecast by Application (2018-2023)

Figure Global Nutritional management Revenue Growth Rate (2013-2018)

Figure Global Pancreatic enzyme replacement therapy (PERT) Revenue Growth Rate (2013-2018)

Figure Global Life style modifications approach Revenue Growth Rate (2013-2018)

Figure Global Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Exocrine Pancreatic Insufficiency Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Exocrine Pancreatic Insufficiency Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

Figure Europe Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

Figure South America Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Forecast (2018-2023)

Choose License Type